Nexstim Plc (NXTMH)-医療機器分野:企業M&A・提携分析

◆英語タイトル:Nexstim Plc (NXTMH) - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA8011122
◆発行会社(調査会社):GlobalData
◆発行日:2017年12月21日
◆ページ数:54
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:フィンランド
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Nexstim Plc (Nexstim) is a medical technology company, which focuses on navigated brain stimulation (NBS) to improve rehabilitation in stroke patients non-invasively . Its NBS system, which is FDA cleared and CE-marked, applies navigated transcranial magnetic stimulation (nTMS) device for pre-surgical mapping of the motor and speech cortices. It is also used for research, therapy and neurosurgical planning purposes. Nexstim’s navigated brain therapy (NBT) system is based on the NBS technology platform, focusing on the stimulation of targeted areas in the brain to improve and accelerate stroke rehabilitation. The company offers its products in the US, Finland and other European countries through subsidiaries. Nexstim is headquartered in Helsinki, Finland.

Nexstim Plc (NXTMH) – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
Nexstim Plc, Medical Equipment, Deals By Year, 2011 to YTD 2017 6
Nexstim Plc, Medical Equipment Deals By Type, 2011 to YTD 2017 7
Nexstim Plc, Medical Equipment, Deals By Region, 2011 to YTD 2017 8
Nexstim Plc, Medical Equipment, Deals By Market, 2011 to YTD 2017 9
Nexstim Plc, Medical Equipment, Deals Summary, 2011 to YTD 2017 10
Nexstim Plc, Medical Equipment, Deal Details 11
Venture Financing 11
Nexstim Secures Additional US$2.8 Million In Venture Financing Round 11
Partnerships 13
Nexstim Enters into Licensing Agreement with Chinese Partner 13
Nexstim Enters into Co-Operation Agreement with Walton Centre 14
Equity Offering 15
Nexstim to Raise USD2 Million in Private Placement of Shares 15
Nexstim to Raise USD5.5 Million in Private Placement of Shares 16
Nexstim to Raise USD2.2 Million in Private Placement of Shares 18
Nexstim Raises USD5.8 Million in Private Placement of Shares 20
Nexstim Raises USD19 Million in IPO 21
Debt Offering 22
Nexstim to Raise USD5.5 Million in Private Placement of Convertible Bond 22
Nexstim Plc – Key Competitors 24
Nexstim Plc – Key Employees 25
Nexstim Plc – Locations And Subsidiaries 26
Head Office 26
Other Locations & Subsidiaries 26
Recent Developments 27
Financial Announcements 27
Aug 17, 2017: Nexstim Half-yearly Report 1 January – 30 June 2016 (Unaudited) 27
Aug 16, 2017: Nexstim Half-Yearly Report 1 January – 30 June 2017 (Unaudited) 29
Jun 02, 2017: Nexstim Agrees on Extension of Tekes R&D Loan Repayments 31
Feb 28, 2017: Nexstim: Financial Statement Release 2016 32
Feb 29, 2016: Nexstim financial statement release 2015 34
Corporate Communications 36
Oct 12, 2017: Change in Nexstim Management Team 36
Sep 26, 2017: Change in Nexstim’s Management Team 37
Aug 03, 2017: Changes in Nexstim’s Management Team 38
Jun 05, 2017: Nexstim Members of the Board Committees 39
Jun 02, 2017: Nexstim Agrees on Extension of Tekes R&D Loan Repayments 40
Apr 24, 2017: Nexstim Appoints Hanna Kotola as VP of Legal Affairs 41
Mar 28, 2017: Nexstim: The decisions of the Board of Directors 42
Mar 09, 2017: Changes in Nexstim Management Team 43
Apr 21, 2016: Nexstim announces the change of CEO 44
Apr 01, 2016: Nexstim Appoints John Liedtky as VP of Commercialisation, General Manager US and announces the retirement of John Hardin 45
Product News 46
Jan 31, 2017: Neurosurgeons from Germany and USA report on their clinical experience of using Nexstim NBS system 46
Oct 05, 2016: Nexstim Key Technology Patent Granted in EU 47
Other Significant Developments 48
Oct 16, 2017: Nexstim is negotiating an assembly and distribution arrangement in China and a financing arrangement for the financing of its bring-to-market strategy in Europe and the US 48
May 08, 2017: Nexstim Terminates Market Making Agreement with Pareto Securities in Nasdaq First North Sweden 49
Apr 24, 2017: Aarhus University Hospital in Denmark Purchases NBS System from Nexstim 50
Mar 08, 2017: Nexstim announces signing of an Independent Selling Representative Agreement in the U.S. with Surgical Solutions 51
Jan 11, 2017: Nexstim announces signing of an Independent Selling Representative Agreements in U.S. 52
Dec 22, 2016: Nexstim pre-close business update 53
Appendix 54
Methodology 54
About GlobalData 54
Contact Us 54
Disclaimer 54

List of Tables
Nexstim Plc, Medical Equipment, Key Facts, 2015 2
Nexstim Plc, Medical Equipment, Deals Summary, 2011 to YTD 2017 2
Nexstim Plc, Medical Equipment, Deals By Year, 2011 to YTD 2017 6
Nexstim Plc, Medical Equipment Deals By Type, 2011 to YTD 2017 7
Nexstim Plc, Medical Equipment, Deals By Region, 2011 to YTD 2017 8
Nexstim Plc, Deals By Market, 2011 to YTD 2017 9
Nexstim Plc, Medical Equipment, Deals Summary, 2011 to YTD 2017 10
Nexstim Secures Additional US$2.8 Million In Venture Financing Round 11
Nexstim Enters into Licensing Agreement with Chinese Partner 13
Nexstim Enters into Co-Operation Agreement with Walton Centre 14
Nexstim to Raise USD2 Million in Private Placement of Shares 15
Nexstim to Raise USD5.5 Million in Private Placement of Shares 16
Nexstim to Raise USD2.2 Million in Private Placement of Shares 18
Nexstim Raises USD5.8 Million in Private Placement of Shares 20
Nexstim Raises USD19 Million in IPO 21
Nexstim to Raise USD5.5 Million in Private Placement of Convertible Bond 22
Nexstim Plc, Key Competitors 24
Nexstim Plc, Key Employees 25
Nexstim Plc, Subsidiaries 26

★海外企業調査レポート[Nexstim Plc (NXTMH)-医療機器分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Thaivivat Insurance Public Company Limited
    Thaivivat Insurance Public Company Limited - Strategy, SWOT and Corporate Finance Report Summary Thaivivat Insurance Public Company Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, …
  • Alliqua BioMedical Inc (ALQA):医療機器:M&Aディール及び事業提携情報
    Summary Alliqua BioMedical Inc (Alliqua BioMedical), formerly HepaLife Technologies Inc, is a regenerative technology company that builds a suite of regenerative solutions for wound and tissue repair. The company’s products comprise ultrasound healing therapy, human biologics, antimicrobial protecti …
  • Griffon Corporation:企業の戦略・SWOT・財務情報
    Griffon Corporation - Strategy, SWOT and Corporate Finance Report Summary Griffon Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Brookdale Senior Living, Inc.:企業の戦略・SWOT・財務分析
    Brookdale Senior Living, Inc. - Strategy, SWOT and Corporate Finance Report Summary Brookdale Senior Living, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …
  • Reckitt Benckiser Group plc:企業の戦略・SWOT・財務情報
    Reckitt Benckiser Group plc - Strategy, SWOT and Corporate Finance Report Summary Reckitt Benckiser Group plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • Xtant Medical Holdings Inc (XTNT)-製薬・医療分野:企業M&A・提携分析
    Summary Xtant Medical Holdings Inc (Xtant Medical), formerly Bacterin International Holdings, Inc. is a medical device company that develops regenerative medicine products and medical devices. The company’s products include 3Demin, osteosponge, osteosponge SC, osteoselect DBM Putty, OsteoSTX, osteow …
  • Nutreco NV:企業のM&A・事業提携・投資動向
    Nutreco NV - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Nutreco NV Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capi …
  • Biofuels Power Corp (BFLS):企業の財務・戦略的SWOT分析
    Summary Biofuels Power Corp (BFLS), is a renewable energy corporation that develops bio fuels. The corporation operates and develops grid-connected biodiesel power electric generation plants. It produces fuels through transesterification of off-spec oils and gasification of waste products such as gl …
  • Flint Group SA:企業の戦略的SWOT分析
    Flint Group SA - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and service …
  • Diamond Offshore Drilling Inc (DO)-石油・ガス分野:企業M&A・提携分析
    Summary Diamond Offshore Drilling, Inc. (Diamond Offshore) is an offshore oil and gas drilling company, which provides contract drilling services to the energy industry. It operates through a fleet of offshore drilling rigs comprising semisubmersibles, jack-ups, and dynamically positioned drillships …
  • PriceSmart, Inc.:企業の戦略・SWOT・財務情報
    PriceSmart, Inc. - Strategy, SWOT and Corporate Finance Report Summary PriceSmart, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Journey Energy Inc (JOY):石油・ガス:M&Aディール及び事業提携情報
    Summary Journey Energy Inc (Journey Energy), a subsidiary of Maples Investments LP, is an oil and gas company that offers exploration, development and production oil and natural gas assets. The company provides horizontal and multi-frac drilling, and secondary recovery methods that helps in acquirin …
  • OncoSec Medical Inc (ONCS):企業の財務・戦略的SWOT分析
    Summary OncoSec Medical Inc (OncoSec) is a biotechnology company. The company offers services to stimulate body’s immune system and attack cancer. Its lead candidate, ImmunoPulse IL-12, consists of a plasmid construct encoding the proinflammatory cytokine, IL-12, which is delivered into the tumor th …
  • PSA International Pte Ltd:企業の戦略的SWOT分析
    PSA International Pte Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products …
  • Nakheel:企業の戦略・SWOT・財務情報
    Nakheel - Strategy, SWOT and Corporate Finance Report Summary Nakheel - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, pr …
  • NuVasive Inc (NUVA):製品パイプライン分析
    Summary NuVasive Inc (NuVasive) is a medical device company that provides minimally invasive, procedurally-integrated spine solutions. The company principally provides Maximum Access Surgery (MAS), a minimally-disruptive surgical platform. MAS platform enables surgeons to perform a range of minimall …
  • Intermountain Rural Electric Association:発電所・企業SWOT分析
    Intermountain Rural Electric Association - Power Plants and SWOT Analysis, 2017 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, informa …
  • Akzo Nobel NV (AKZA):企業の財務・戦略的SWOT分析
    Akzo Nobel NV (AKZA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Allied Cooperative Insurance Group:企業の戦略・SWOT・財務情報
    Allied Cooperative Insurance Group - Strategy, SWOT and Corporate Finance Report Summary Allied Cooperative Insurance Group - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, p …
  • Specialist Computer Centres Plc:企業の戦略・SWOT・財務情報
    Specialist Computer Centres Plc - Strategy, SWOT and Corporate Finance Report Summary Specialist Computer Centres Plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆